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Guest Editorial
Diagnostically Homeless and Needing 
Appropriate Placement
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Volume 15, Number 3, 2005
© Mary Ann Liebert, Inc.
Pp. 337–343
THIS ISSUE OF JCAP focuses on children andadolescents with symptoms that suggest
possible psychosis and/or disordered thinking.
Their presentation arises from high-risk status
because of strong family history of schizophre-
nia, developmental disorders where thought
versus language communication is abnormal,
and from atypical “psychotic” symptoms. In
many ways, these young people are “diagnos-
tically homeless” because they do not truly meet
criteria for a Diagnostic and Statistical Manual of
Mental Disorders (DSM) diagnosis, are given a
“not otherwise specified” designation, and are
never seriously studied in any systematic man-
ner. The latter problem arises because they are
either grouped with people who do meet crite-
ria, or are excluded from study because they do
not meet criteria for our nosological categories
This issue is a perfect one to dedicate to Bar-
bara Fish, M.D., who is a pioneer child psychi-
atrist in the study of children at high risk for
schizophrenia. She is one of the world leaders
in the area of high-risk research in children and
adolescents. We are honored to know her, to
know her work, and to have her as a central
contributor to this volume. Dr. Ted Shapiro,
one of Dr. Fish’s students, early collaborators,
and a clinical investigator in his own right, has
written a wonderful tribute to Dr. Fish, high-
lighting not only the importance of her work,
but also the profound influence that she has had
on numerous individuals in the field of child
psychiatry, many of whom have become lead-
ers in child psychiatric research. In fact, many
of the contributors to this issue are Dr. Fish’s
professional first- or second-degree relatives (i.e.,
colleagues, mentees, and mentees of mentees). 
Dr. Fish will be remembered for being one of
the first people to demonstrate that early ab-
normalities of neurodevelopment were highly
correlated with the development of schizophre-
nia spectrum manifestations. This is a finding
that investigators continue to demonstrate (Carl-
son 2004). From a clinical standpoint, Dr. Fish’s
dedicated study of 23 people, from infancy
through young adulthood, provides clinical in-
sight into manifestations of serious psychopa-
thology unlikely ever to be replicated. Detail is
presented not only in terms of whether a symp-
tom was present or absent, but how it actually
appeared to the interviewer (Table 2 in the Fish
and Kendler paper and Table 2 in the Carlson
and Fish paper). Such detail is absent from
more modern rating scales that tell you quan-
tity and severity but not quality of symptoms.
The papers in this issue fall into three dis-
tinct categories: Those addressing schizophrenia
spectrum disorders, those addressing studies
of children at high risk to develop schizophre-
nia by virtue of their prodromal psychotic symp-
toms and/or family history, and papers which
focus on children who have developmental dis-
orders with multiple domains of dysfunction
and comorbidities that can be confused with
psychosis.
Schizophrenia spectrum conditions
Four papers address the question of the clini-
cal aspects of schizophrenia spectrum symp-
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toms in children. Three are from high-risk
samples (Fish and Kendler, Carlson and Fish,
Hans et al.), and one is a follow up study
(Asarnow)
The first two papers in this issue consider
the history of schizophrenia spectrum disorders
from the inception of the concept of schizotypy
by Paul Meehl in 1962 to the creation of criteria
for schizotypal personality disorder for DSM-
III. Interestingly, conceptualization of schizo-
phrenia-like manifestations in children never
appeared to be part of the thinking and devel-
oped its own line of research with, as usual,
the child psychopathologists learning from re-
search on adults, but, sad to say, no evidence
of fertilization in the opposite direction.
An examination of the meticulously gath-
ered, prospectively collected data on the cases
reported in the papers by Dr. Fish, and Hans
et al. reveal two important findings. Firstly,
elementary school children with a variety of
behavioral (e.g., aggression), developmental
(wide-ranging skill deficits), and emotional
(anxious, depressed appearing) symptoms can
be distinguished from other children with such
symptoms by their social isolation, apathy, mild
thought disorder, and suspiciousness. These
“negative” symptoms, more than psychosis,
seem to set them apart. Secondly, long-term
follow-up demonstrates the persistence of symp-
toms. In two cases (Andy from Carlson and
Fish; David from Hans et al.), a mood disorder
was superimposed on the backdrop of schizo-
typy but did not change the overall course.
Confirmatory evidence comes from Asarnow’s
shorter-term follow-up study with data col-
lected in more “modern” ways (e.g., semistruc-
tured interviews, specific criteria elicitation).
Not only was schizotypy stable in half the cases,
but even in this sample, where mood disorders
were later manifested, schizotypal symptoms
persisted (hence, schizoaffective and atypical
bipolar designations). 
Perhaps, then, rather than saying that “per-
sonality disorders have an onset in adolescence
and early adulthood,” thus leaving children di-
agnostically homeless, a clarification is neces-
sary. This supports the belief that adults with
certain “personality disorders” may not have
personality disorders at all, but rather an Axis
1 spectrum condition that, like the Axis 2 dis-
order, can be evident at any age,
Implications of psychosis for the development
of schizophrenia
The paper by Stone et al. is a theoretical paper
which bridges the gap between the clinical phe-
nomenology of schizotypy manifestations to
the liability to schizophrenia (called “schizo-
taxia”). Rather than examining children, the
paper reviews genetic high-risk studies and as-
sesses them for features that may be related to
schizotaxia or core features of genetic liability.
A reading of the tables in this paper reveals the
common denominators found in genetic high-
risk studies (schizotaxia) and schizotypy. Not
surprisingly, there is considerable overlap be-
tween the risk factors found in large, genetic
high-risk studies (Stone et al.; Tables 3 and 4)
and the clinical symptoms of schizotypy re-
ported by Carlson and Fish (Tables 2 and 4).
The authors conclude by saying that high-risk
studies are important for a variety of reasons,
including the ultimate identification and vali-
dation of specific liability syndromes.
There are two approaches to understanding
liability to severe psychiatric disorder—in this
case, psychosis and schizophrenia. Firstly, there
are the genetic high-risk projects that research
individuals at-risk for developing psychosis
based upon having a first-degree relative with
schizophrenia. Dr. Fish, and somewhat later
Drs. Erlenmeyer Kimling and Cornblatt, and
also Marcus and Hans, played major roles in
this field of research. More recently, methodol-
ogy has focused on ultra high-risk studies.
These go beyond the genetic vulnerability and
identify clinical features that are indicative of
heightened vulnerability for the imminent onset
of psychosis.
The challenge is to define the prodrome of
psychosis. Prodrome is the period preceding
the first episode of psychotic illness and consists
of an emergence of nonspecific psychiatric dif-
ficulties that are subtle and pose significant
diagnostic and treatment dilemmas. A central
goal of ultra high-risk research is to develop a
system for identifying patients during the pro-
drome of illness so that they can be monitored,
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and so that treatment delays can be reduced.
This issue includes four papers that examine
children and adolescents with psychotic symp-
toms that do not meet criteria for schizophre-
nia or mood disorder with psychosis, and the
goal is to determine the course of those symp-
toms, and the clinical entities in the youths
manifesting them. 
Meyer et al. provide an excellent review
of the issues and concepts of prodrome as it
has evolved in recent decades. As part of the
University of California—Los Angeles (UCLA)
Center for the Assessment and Prevention of
Prodromal States, the authors systematically
characterized 24 adolescent patients felt to be
at imminent risk for psychosis. It was neces-
sary to screen 139 subjects who were thought
to be prodromal, in order to find these 24 who
were symptomatic enough to be prodromal, but
were not so symptomatic they were already
psychotic. Necessary to characterize the subtle
symptoms these youths manifest are a number
of sensitive and lengthy interviews designed
to elicit the cognitive and behavioral pathol-
ogy not always evident in the usual structured
interviews used in child psychiatry research.
Attenuated positive symptoms were most prom-
inent in this sample (perceptual abnormalities/
hallucinations and unusual thought content),
for which reason they were felt to be in the
“late prodromal phase.” Many already had sig-
nificant social and attentional problems. Major
depressive disorder was diagnosable in half
the sample, but at least as important were wide-
ranging subsyndromal conditions. The ques-
tion is whether these patients will stabilize at
this point and remain more schizotypal or con-
tinue into a full-blown psychosis. 
Also using the ultra high-risk paradigm,
Correll et al. describe their adolescent prodro-
mal sample from the Zucker Hillside Hospital’s
Recognition and Prevention Program. The meth-
odology, not surprisingly, is similar to that de-
scribed in the UCLA project. However, Correll
et al. chose to emphasize and review the impli-
cations of heterogeneity of psychotic symptoms
that were either fewer in number than required
for schizophrenia (“psychosis not otherwise
specified (NOS)”) and or lasting more than a
day and less than a month (“brief psychosis”).
Like other diagnostically homeless youths, those
with either of these two diagnostic entities have
been neglected in terms of systematic research
and are variably included, if at all, in either the
at-risk group or in the outcome group (schizo-
phrenia).
In the study by Correll et al., 29 youths were
characterized at baseline, and 26 were avail-
able for follow up (>6 months). These authors
found that the diagnoses of psychosis NOS
(n = 22) and brief psychotic disorder (n = 4) are
unstable and heterogeneous entities. The psy-
chosis in 3 of the teens with brief psychotic dis-
order had remitted as had the psychosis in 7 of
those with psychosis NOS. On the other hand,
9 had progressed to further psychosis (5 schiz-
ophrenia, 3 bipolar with psychosis, 1 schizoaf-
fective). The underlying, or additional Axis I
disorder remained, for the most part. 
Hlastala and McClellan characterize the phe-
nomenology and diagnostic stability of youths
in a long-term psychiatric hospital with atypi-
cal psychotic symptoms. In a 2-year follow-up
study, they compared three groups of youths;
those with atypical psychosis, those with schiz-
ophrenia, and those with bipolar disorder with
psychotic features. They assessed general symp-
toms, comorbid diagnoses, prior abuse, and
overall functioning. Like Correll et al., the au-
thors found that those with atypical psychotic
symptoms were very heterogeneous. None de-
veloped classic psychotic illness by the 2-year
follow-up. These individuals with atypical fleet-
ing or situationally specific hallucinations had
higher rates of abuse, dissociative symptoms,
and were more likely to have posttraumatic
stress disorder or a depressive disorder than cur-
rent or true prodromal psychotic illness. These
authors conclude it is not even appropriate to
designate some symptoms as truly psychotic.
Finally, Stayer et al. tackle the diagnostically
homeless children from the National Institutes
of Mental Health (NIMH) Early Onset Schizo-
phrenia project for whom a new term, “multidi-
mensionally impaired,” had to be coined to
classify the children. In this research designa-
tion, the psychotic symptoms were defined as
“poor ability to distinguish fantasy from reality
as evidence by ideas of reference and brief per-
ceptual disturbances during stressful periods or
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while falling asleep.” These symptoms were su-
perimposed on children who appeared to have
affective dysregulation and attention-deficit/
hyperactivity disorder (ADHD)-like symptoms.
The thrust of this paper is that some of the chil-
dren (5 of 32) were virtually asymptomatic,
though the remainder were still significantly im-
paired (4 of the 10 had ongoing psychosis and
all 10 continued to have severe behavioral disor-
ders) albeit not schizophrenia.
Diagnostically homeless with possible
pervasive developmental disorder
Children with developmental disorders tend
to present to clinics with multiple domains of
dysfunction, including the areas of mood reg-
ulation, attention, and thinking. These youths
also have some features of pervasive develop-
mental disorder and a number of non-DSM cat-
egories have been proposed over the years to
more accurately capture these nosological or-
phans, including: Childhood-onset pervasive
developmental disorder (PPD) (DSM-III; Amer-
ican Psychiatric Association, 1980), multiplex
developmental disorder (Towbin et al. 1993;
Cohen et al. 1987), multiple complex develop-
mental disorder (MCDD; Buitelaar et al.
1998; Buitelaar et al. 1999; Van der Gaag et al.
1995), and multidimensionally impaired disor-
der (McKenna et al. 1994). These children are
quite common within clinical settings, yet little
is known about them longitudinally and in
terms of treatment interventions. The reasons for
the lack of knowledge and progress as it pertains
to these youth is complicated, but it is clear
that research in these children has been some-
what hampered by the fact that they do not fit
into our nosological categories in a clear way.
The first issue that arises in examining chil-
dren with atypical PDD symptoms is whether
and how they differ from children with high-
functioning autism. Van Der Gaag et al. pro-
vide an excellent summary of an often vexing
distinction—that between a language disorder
and a thought disorder. Then, using Caplan’s
Kiddie Formal Thought Disorder (FTD) Story
Game and Rating Scale (Caplan et al. 1989) to
systematically assess thought disorder, they
examined children with clear high-functioning
autism, those with “MCDD,” children with two
other psychiatric disorders (anxiety and atten-
tion-deficit/hyperactivity disorder), and nor-
mal children. The authors found that the
autism and MCDD groups had similar rates of
formal thought disorder and were clearly dif-
ferent from the other groups. Loose associations
were almost specific for the PDD groups. While
these findings suggest that MCDD is an autism
spectrum condition, the authors also conclude
that FTD in the autism and MCDD populations
probably reflect pragmatic, discourse, and spe-
cific information-processing deficits rather than
schizophrenic-like thought disorder. Misdiag-
nosis of such children as having schizophre-
nia, then, is quite easy, and one suspects that
such young people have found their way into
studies of schizophrenia. This is not a trivial
problem, considering the different treatment
implications for autism and schizophrenia.
Another question that arises when examin-
ing children who have some symptoms of per-
vasive developmental disorder is how much
the constellation of symptoms that certainly
appear to be on the autism spectrum should
represent a legitimate comorbidity that needs
its own designation (e.g., multiple complex
developmental disorder, childhood-onset per-
vasive developmental disorder). Two papers
discuss its comorbidity with other Axis I disor-
ders. For instance, the study by Towbin et al.
evaluated the presence of autism spectrum dis-
order symptoms (ASD) in youths in a mood
and anxiety disorders program. They tried to
exclude children with known autism or As-
pergers’ disorder but found, using the Social
Communication Questionnaire, Children’s Com-
munication Checklist and Social Reciprocity
Scale, that 62% of the 93 patients enrolled in
the programs screened positive for a possible
ASD on one of the instruments that the authors
used. One case example illustrates obvious co-
morbid bipolar disorder with this autism spec-
trum condition. 
It is instructive to note that the three instru-
ments used in the Towbin et al. paper to mea-
sure some of the same constructs are hardly
mutually inclusive. One (Social Communica-
tion Questionnaire) is basically an instrument
developed to screen for autism, and is the most
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conservative instrument. The Children’s Com-
munication Checklist really hones in on lan-
guage disorders with some symptoms that pick
up on autism. The Social Reciprocity Scale
includes items that address autism, immatu-
rity, schizotypy, and general peer relationships.
Thus, each tells us something different about
the sample of bipolar and mood-dysregulated
children. Given the impact of language dys-
function and peer relationships on outcome,
however, the absence of a way to classify this
comorbidity means that we cannot usefully pre-
dict outcome, except as the tried and true “poor
premorbid functioning” variable that broadly
assesses the same issues.
Weisbrot et al. examine the frequency of
anxiety symptoms in preschool and 6–12-year-
old clinic children with and without pervasive
developmental disorder symptoms. In this case,
the authors use parent and teacher endorse-
ments on the Early Childhood Inventory (Gadow
and Sprafkin 1997) and the Child Symptom In-
ventory (Gadow and Sprafkin 2002) to classify
the children. What makes these children espe-
cially complex diagnostically is the fact that
they also have significant rates of psychotic
symptoms, compared to nonanxious children.
Anxiety and psychosis are well-accepted “co-
morbidities” in people without developmental
disorder. Although the psychosis was related
to the degree of anxiety, rather than PDD, one
might speculate that a youngster who has so-
cial oddities, pragmatic language problems, and
psychotic-like symptoms might well be mis-
taken for having a schizophrenia-related dis-
order. This is less likely to happen in a child
without this developmental complication.
The volume ends with an interesting and
complicated case of a teenage girl with an un-
derlying mitochondrial disorder who has psy-
chiatric symptoms. The case report discusses
the neuropsychiatric manifestations that can be
seen in these youths and highlights the some-
times atypical response of these individuals to
psychotropics. In this case, the awareness of
JM’s doctors of this unique drug-induced re-
sponse saved the patient from a psychosis diag-
nosis, and more importantly, from treatments
that might have made her worse. The authors
emphasize the need for systematic evaluation
of treatments for emotional and behavioral
symptomatology in youths with these disorders.
CONCLUSION
The reader may wonder why a JCAP issue
addresses no psychopharmacology. It seems to
us that the clinical implications of these pur-
ported psychotic symptoms in children and
adolescents is wide ranging. Firstly, a diverse
group of authors with different backgrounds
and studies have ended up reporting on issues
with considerable similarity. Also, mild nega-
tive symptoms are disabling, enduring, and can
start early in life. They have clear neurodevel-
opmental origins. Secondly, not all psychotic
symptoms are created equally. Some are tran-
sient, in fact, and appear to be superimposed,
almost incidentally, on other Axis I conditions.
Thirdly, some are phenocopies and, in the con-
text of a pervasive developmental or autism
spectrum disorder, can be misinterpreted as
psychosis. Absent of a good way to classify
children with these symptoms, measure them
reliably, and study their treatment, these diag-
nostically homeless children are likely to be
exposed to treatments they may not need and
not given treatments they do need.
Instruments and interviews to further study
this population of children will need to include
developmental assessments for pervasive devel-
opmental disorder, prodromal symptoms, Axis I
disorders, and cognitive and language function-
ing. Conspicuously absent from most of these
otherwise excellent papers is any feeling for what
the content of the hallucinations, delusions, and
negative symptoms were. Although reliable rat-
ings help us quantify the problems, they clearly
have not helped us distinguish clinically the in-
consequential from the serious problems nor do
they help a clinician recognize and distinguish
differences. Perhaps only other, nonpsychotic
symptoms, or imaging or biological markers, will
be able to do that. Family histories will need to
include not only adult Axis I disorders but also
possible childhood disorders that may have per-
sisted in parents (e.g., partially remitted autism
spectrum disorders, schizotypal personality dis-
order, learning and language disorders).
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With better assessment and classification in
place, we may be able to dedicate a future issue
to formerly diagnostically homeless children
who have not only found respite but also ap-
propriate treatment.
—Jean A. Frazier, M.D.
—Gabrielle A. Carlson, M.D.
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Dr. Barbara Fish (front row, center) at a lunch with colleagues, friends, and protégées from UCLA-Neuropsychiatric
Institute, January, 2003.  (Dr. Fish was recovering from a fractured hip). People pictured from left to right:  Gabrielle A.
Carlson, MD, Barbara Fish, MD, Margaret Stuber, MD, Joan Asarnow, PhD, Marian Sigman, PhD, Bonnie Zima, MD,
Rochelle Caplan, MD
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